National Research Corporation logo
NRCNational Research Corporation

EV/EBITDA Ratio: 19.11x

Is the EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 19.11x is 14% above its 5-year average of 16.78x, around the middle of its 5-year range (7.20x–26.40x).

As of Saturday, June 27, 2026. 42.72% above its 12-month average of 13.39x.

NRC EV/EBITDA Ratio

NRC EV/EBITDA Ratio Chart

19.11x
+80.97% 1Y
NRC EV/EBITDA Ratio

NRC Average EV/EBITDA Ratio Chart

NRC EV/EBITDA Ratio

NRC Current vs Average EV/EBITDA Ratio Chart

NRC EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

19.11x

EV/EBITDA RATIO AVG TTM

13.39x

EV/EBITDA RATIO AVG 3Y

15.09x

EV/EBITDA RATIO AVG 5Y

16.78x

EV/EBITDA RATIO AVG 10Y

20.40x

EV/EBITDA RATIO AVG 15Y

N/A

EV/EBITDA RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+42.72%

CURRENT VS 3Y AVG

+26.65%

CURRENT VS 5Y AVG

+13.87%

CURRENT VS 10Y AVG

-6.32%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

NRC Competitors' EV/EBITDA Ratio

NAMEMARKET CAPEV/EBITDA RATIOTTM3Y5Y
National Research Corporation (NRC)$468.99M19.11x13.39x15.09x16.78x
Shoulder Innovations, Inc. (SI)vs ›$472.62MN/AN/AN/AN/A
23andMe Holding Co. (ME)vs ›$15.31MN/AN/AN/AN/A
Teladoc Health, Inc. (TDOC)vs ›$1.51B42.51x37.00x270.07x270.07x
DENTSPLY SIRONA Inc. (XRAY)vs ›$2.21B7.64x7.50x41.47x29.03x
TransMedics Group, Inc. (TMDX)vs ›$2.37B22.61x42.68x93.84x93.84x
Hims & Hers Health, Inc. (HIMS)vs ›$7.57B87.10x66.28x327.19x327.19x
Oscar Health, Inc. (OSCR)vs ›$7.72B136.96x60.29x46.36x46.36x
Bio-Rad Laboratories, Inc. (BIO)vs ›$8.13B20.52x20.87x19.59x22.00x
Universal Health Services, Inc. (UHS)vs ›$9.12B5.25x6.96x8.30x8.25x

EV/EBITDA vs. its own history

At 19.1, EV/EBITDA is in its normal range, sitting higher than 58% of its 13-year history.

13-year low

5.5

median

17.2

13-year high

41.2

cheaperricher

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for National Research Corporation (NRC)?
The EV/EBITDA ratio for NRC stock is 19.11x.
Is National Research Corporation's EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 19.11x is 14% above its 5-year average of 16.78x, around the middle of its 5-year range (7.20x–26.40x).
What is the TTM average EV/EBITDA ratio for National Research Corporation (NRC)?
The TTM average EV/EBITDA ratio for NRC stock is 13.39x.
What is the 3Y average EV/EBITDA ratio for National Research Corporation (NRC)?
The 3Y average EV/EBITDA ratio for NRC stock is 15.09x.
What is the 5Y average EV/EBITDA ratio for National Research Corporation (NRC)?
The 5Y average EV/EBITDA ratio for NRC stock is 16.78x.
What is the 10Y average EV/EBITDA ratio for National Research Corporation (NRC)?
The 10Y average EV/EBITDA ratio for NRC stock is 20.40x.

NRC EV/EBITDA Ratio History

DATEEV/EBITDA RATIO
2026-06-2619.11x
2026-06-2518.90x
2026-06-2419.02x
2026-06-2318.50x
2026-06-2218.07x
2026-06-1817.32x
2026-06-1716.70x
2026-06-1617.26x
2026-06-1517.14x
2026-06-1217.52x
2026-06-1117.52x
2026-06-1019.48x
2026-06-0918.27x
2026-06-0817.94x
2026-06-0517.79x
2026-06-0418.27x
2026-06-0317.71x
2026-06-0218.15x
2026-06-0118.67x
2026-05-2918.10x
2026-05-2818.20x
2026-05-2717.78x
2026-05-2617.71x
2026-05-2217.75x
2026-05-2117.71x
2026-05-2017.89x
2026-05-1917.49x
2026-05-1817.48x
2026-05-1517.38x
2026-05-1417.63x
2026-05-1317.42x
2026-05-1217.83x
2026-05-1117.45x
2026-05-0817.49x
2026-05-0717.47x
2026-05-0616.78x
2026-05-0516.01x
2026-05-0415.63x
2026-05-0115.05x
2026-04-3014.36x
2026-04-2914.42x
2026-04-2814.63x
2026-04-2714.83x
2026-04-2414.92x
2026-04-2314.93x
2026-04-2215.11x
2026-04-2114.88x
2026-04-2015.60x
2026-04-1715.49x
2026-04-1615.20x
2026-04-1515.36x
2026-04-1414.78x
2026-04-1314.62x
2026-04-1014.37x
2026-04-0914.79x
2026-04-0814.94x
2026-04-0714.78x
2026-04-0614.99x
2026-04-0214.86x
2026-04-0114.99x
2026-03-3114.73x
2026-03-3014.85x
2026-03-2714.84x
2026-03-2615.12x
2026-03-2514.88x
2026-03-2415.07x
2026-03-2315.12x
2026-03-2014.98x
2026-03-1914.97x
2026-03-1815.16x
2026-03-1715.28x
2026-03-1615.04x
2026-03-1314.40x
2026-03-1214.39x
2026-03-1114.03x
2026-03-1014.22x
2026-03-0913.28x
2026-03-0613.01x
2026-03-0512.61x
2026-03-0410.85x
2026-03-0311.02x
2026-03-0211.32x
2026-02-2711.03x
2026-02-2611.05x
2026-02-2510.72x
2026-02-2410.43x
2026-02-2310.44x
2026-02-2011.21x
2026-02-1910.41x
2026-02-1810.33x
2026-02-1710.13x
2026-02-1310.16x
2026-02-1210.66x
2026-02-1111.26x
2026-02-1011.79x
2026-02-0912.32x
2026-02-0612.69x
2026-02-0512.68x
2026-02-0412.25x
2026-02-0313.79x
2026-02-0216.59x
2026-01-3015.57x
2026-01-2915.38x
2026-01-2815.23x
2026-01-2715.58x
2026-01-2615.88x
2026-01-2316.05x
2026-01-2216.67x
2026-01-2116.97x
2026-01-2016.59x
2026-01-1616.80x
2026-01-1516.20x
2026-01-1415.90x
2026-01-1315.93x
2026-01-1215.63x
2026-01-0915.17x
2026-01-0815.02x
2026-01-0714.63x
2026-01-0614.89x
2026-01-0514.56x
2026-01-0214.06x
2025-12-3114.54x
2025-12-3014.47x
2025-12-2914.68x
2025-12-2614.47x
2025-12-2414.57x
2025-12-2314.70x
2025-12-2214.62x
2025-12-1914.50x
2025-12-1814.89x
2025-12-1714.46x
2025-12-1614.32x
2025-12-1514.04x
2025-12-1213.80x
2025-12-1113.66x
2025-12-1013.34x
2025-12-0912.76x
2025-12-0812.63x
2025-12-0512.65x
2025-12-0412.94x
2025-12-0312.84x
2025-12-0212.86x
2025-12-0113.25x
2025-11-2813.38x
2025-11-2613.56x
2025-11-2514.05x
2025-11-2413.59x
2025-11-2113.82x
2025-11-2013.13x
2025-11-1912.93x
2025-11-1812.76x
2025-11-1712.74x
2025-11-1412.23x
2025-11-1312.43x
2025-11-1212.36x
2025-11-1112.03x
2025-11-1011.74x
2025-11-0711.88x
2025-11-0611.75x
2025-11-0511.57x
2025-11-0411.38x
2025-11-0311.02x
2025-10-3111.10x
2025-10-3010.92x
2025-10-2911.16x
2025-10-2811.02x
2025-10-279.81x
2025-10-249.97x
2025-10-239.97x
2025-10-2210.13x
2025-10-2110.25x
2025-10-2010.15x
2025-10-179.93x
2025-10-169.98x
2025-10-159.83x
2025-10-149.87x
2025-10-139.85x
2025-10-109.85x
2025-10-0910.01x
2025-10-0810.14x
2025-10-0710.21x
2025-10-0610.24x
2025-10-0310.33x
2025-10-0210.50x
2025-10-0110.53x
2025-09-3010.71x
2025-09-2910.71x
2025-09-2611.06x
2025-09-2511.42x
2025-09-2411.89x
2025-09-2311.97x
2025-09-2212.33x
2025-09-1912.05x
2025-09-1812.78x
2025-09-1712.79x
2025-09-1612.89x
2025-09-1512.98x
2025-09-1212.86x
2025-09-1112.98x
2025-09-1012.78x
2025-09-0912.94x
2025-09-0812.69x
2025-09-0512.45x
2025-09-0412.16x
2025-09-0312.01x
2025-09-0212.23x
2025-08-2911.98x
2025-08-2811.95x
2025-08-2712.51x
2025-08-2612.44x
2025-08-2512.36x
2025-08-2212.43x
2025-08-2111.86x
2025-08-2012.67x
2025-08-1912.96x
2025-08-1812.53x
2025-08-1512.39x
2025-08-1412.19x
2025-08-1312.57x
2025-08-1212.54x
2025-08-1112.25x
2025-08-0812.25x
2025-08-079.73x
2025-08-069.43x
2025-08-059.23x
2025-08-049.15x
2025-08-018.55x
2025-07-318.50x
2025-07-308.58x
2025-07-298.93x
2025-07-289.31x
2025-07-259.28x
2025-07-249.41x
2025-07-239.75x
2025-07-229.43x
2025-07-219.37x
2025-07-189.46x
2025-07-179.87x
2025-07-169.87x
2025-07-159.96x
2025-07-1410.11x
2025-07-1110.44x
2025-07-1010.61x
2025-07-0910.87x
2025-07-0810.94x
2025-07-0710.72x
2025-07-0311.02x
2025-07-0210.76x
2025-07-0110.83x
2025-06-3010.90x
2025-06-2710.83x
2025-06-2610.56x
2025-06-2510.93x
2025-06-2411.15x
2025-06-2311.02x
2025-06-2010.76x
2025-06-1810.92x
2025-06-1710.89x
2025-06-1610.81x
2025-06-1310.48x

Showing the most recent 260 of 3,293 data points. The chart above shows the full history.

About National Research Corporation

National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.

Lincoln, NE
368 employees
Healthcare / Medical - Healthcare Information Services
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Trent Green